Related Experiment Video
Updated: May 7, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Transcriptomics and AI-driven approaches to the diagnosis and treatment of rheumatoid arthritis
Marzena Ciechomska1, Maciej Oldak1,2,3, Magdalena Massalska1
1Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology, and Rehabilitation (NIGRiR), Warsaw, Poland.
Abstract:
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder marked by joint swelling, pain, and progressive tissue destruction. Increasing evidence suggests that dysregulated RNA expression critically drives RA progression by perturbing immune, inflammatory, and stromal cell programs. These aberrant transcriptional signatures offer valuable biomarkers for diagnosis, prognosis, and therapeutic stratification. Recent advances in transcriptomic technologies have transformed our understanding of RA biology. Bulk RNA profiling has highlighted key dysregulated pathways and disease-associated molecular signatures. Single-cell transcriptomics has expanded this insight by defining extensive cellular heterogeneity and uncovering rare immune and stromal populations implicated in disease initiation, progression, and treatment response. The emergence of spatial transcriptomics provides an additional dimension by preserving tissue architecture, enabling precise localisation of pathogenic cell states and mapping cell-cell interactions within inflamed joints and other affected tissues. Integration of transcriptomic datasets with advanced computational and machine learning (ML) methods has accelerated biomarker discovery. Techniques such as Random Forest, XGBoost, support vector machines (SVM), artificial neural networks (ANNs), and Least Absolute Shrinkage and Selection Operator (LASSO) regression facilitate feature selection and prediction from high-dimensional data. Complementary network- and pathway-based tools, including Weighted Gene Co-expression Network Analysis (WGCNA) and Gene Set Variation Analysis (GSVA), uncover co-regulated modules and refine clinically relevant signatures. Collectively, this review aims to provide an update on how the integration of transcriptomics, spatial technologies, and advanced algorithms offers powerful opportunities to identify novel biomarkers and pathogenic cell populations, thereby advancing precision medicine in RA.
Insights
Dysregulated RNA expression drives rheumatoid arthritis (RA) progression. Integrating transcriptomics, spatial technologies, and machine learning aids discovery of biomarkers and cell targets for precision medicine in RA.
Area of Science:
- Rheumatology and Immunology
- Genomics and Bioinformatics
- Computational Biology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and destruction.
- Aberrant RNA expression significantly contributes to RA pathogenesis by altering cellular functions.
- Transcriptomic signatures hold potential as biomarkers for RA diagnosis, prognosis, and treatment stratification.
Purpose of the Study:
- To review advancements in transcriptomic technologies for understanding RA.
- To highlight the role of computational and machine learning methods in biomarker discovery for RA.
- To discuss the integration of transcriptomics, spatial technologies, and algorithms for precision medicine in RA.
Main Methods:
- Bulk RNA sequencing to identify key pathways and molecular signatures in RA.
- Single-cell transcriptomics to analyze cellular heterogeneity and identify disease-implicated cell populations.
- Spatial transcriptomics to map cellular interactions within inflamed tissues.
- Machine learning algorithms (e.g., Random Forest, XGBoost, SVM, ANNs, LASSO) for feature selection and prediction.
- Network and pathway analysis tools (e.g., WGCNA, GSVA) to uncover co-regulated gene modules.
Main Results:
- Transcriptomic profiling has revealed critical dysregulated pathways and molecular signatures in RA.
- Single-cell analyses have identified extensive cellular heterogeneity and rare cell populations involved in RA.
- Spatial transcriptomics enables precise localization of pathogenic cell states and mapping of cell-cell interactions.
- Integration with computational methods accelerates the discovery of predictive biomarkers and therapeutic targets.
Conclusions:
- The integration of transcriptomics, spatial technologies, and advanced algorithms provides powerful tools for RA research.
- Novel biomarkers and pathogenic cell populations can be identified to advance precision medicine approaches for RA.
- These integrated approaches are transforming the understanding and management of rheumatoid arthritis.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Pharmacogenomics: Identification of New Drug Targets
Experimental RNAi
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

